| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/09/2000 | EP0977570A1 Quinoxaline in triple combination with protease inhibitors and reverse transcriptase inhibitors as medicines for treating aids |
| 02/09/2000 | EP0977567A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 02/09/2000 | EP0977555A1 Pharmaceutical preparations and methods for their regional administration |
| 02/09/2000 | EP0977482A1 IDENTIFICATION OF POLYNUCLEOTIDES ENCODING NOVEL $i(HELICOBACTER) POLYPEPTIDES IN THE $i(HELICOBACTER) GENOME |
| 02/09/2000 | EP0610260B1 Vaccines for actinobacillus pleuropneumoniae |
| 02/09/2000 | CN1244203A 抗原 Antigen |
| 02/09/2000 | CN1244202A Tricyclic erythromycin derivatives |
| 02/09/2000 | CN1244121A Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides |
| 02/09/2000 | CN1243751A Method for induction of immunity against virus |
| 02/09/2000 | CN1243732A Chinese medicine 'Baoeryin' and its preparing process |
| 02/09/2000 | CN1243727A Medicinal pill for clearing away lung heat and treating pulmonary tuberculosis |
| 02/09/2000 | CN1049223C Improved meninggococcal polysaccharide conjugate vaccine |
| 02/09/2000 | CN1049215C Pharmaceutical compounds |
| 02/08/2000 | US6022983 Preparing a myxopyronin |
| 02/08/2000 | US6022900 Preventing and ameliorating cachexia; treating whole body nitrogen loss associated with catabolic illness by inhibiting synthesis of urea from plasma arginine |
| 02/08/2000 | US6022884 Substituted pyridine compounds and methods of use |
| 02/08/2000 | US6022876 L-β-dioxolane uridine analogs and methods for treating and preventing Epstein-Barr virus infections |
| 02/08/2000 | US6022864 Nucleic acid respiratory syncytial virus vaccines |
| 02/08/2000 | US6022855 Novel variants of the naturally-occurring protease inhibitor, alpha1-antitrypsin and derived peptides comprising a sequence of-arg-xaa-xaa-arg-; viricides; bactericides; blocking of endoproteolytic activation of a bacterial toxin |
| 02/08/2000 | US6022851 Cyclic polypeptides for treatment and prophylaxis of antibiotic-resistant bacterial infectious diseases by administration with an excipient |
| 02/08/2000 | US6022735 Composition for introducing nucleic acid complexes into higher eucaryotic cells |
| 02/08/2000 | US6022726 Genetically engineered attenuated viruses |
| 02/08/2000 | US6022543 Hepatitis B surface antigen vaccine |
| 02/08/2000 | US6022542 Polypeptide which serves as reagent in diagnostic kit for detecting an anti-herpesvirus antibody present in a biological sample; kaposi's sarcoma (ks) and retroperitoneal fibromatosis (rf) |
| 02/08/2000 | US6022311 Apparatus and method for a custom soft-solid hearing aid |
| 02/08/2000 | CA2127677C 2-bromo- and 2-nitroxy derivatives of 3-bromo- and 3.3-dibromo-4-oxo-azetidines, processes for the preparation thereof and use thereof |
| 02/08/2000 | CA2004597C Topical formulations and transdermal delivery systems containing 1-isobutyl-1h-imidazo-[4,5-c]quinoline-4-amine |
| 02/03/2000 | WO2000005388A1 Genes of the dead box protein family, their expression products and use |
| 02/03/2000 | WO2000005371A1 Keratinocyte derived interferon |
| 02/03/2000 | WO2000005362A1 Mekk1(serine threonine kinases)-interacting fha (forkhead associated domain) protein 1 (mif1) |
| 02/03/2000 | WO2000005348A1 Pneumococcal nrdg protein |
| 02/03/2000 | WO2000005270A1 Biocompatible polymers, preparation method and compositions containing same |
| 02/03/2000 | WO2000005269A1 Polymer complexes of glucuronoglucanes |
| 02/03/2000 | WO2000005266A1 Anti hepatitis c virus antibody and uses thereof |
| 02/03/2000 | WO2000005265A2 Anti-crr2 antibodies and methods of use therefor |
| 02/03/2000 | WO2000005259A1 Secreted cysteine rich protein-6 (scrp-6) |
| 02/03/2000 | WO2000005251A1 Aerothricin analogs, their preparation and use |
| 02/03/2000 | WO2000005245A2 Inhibitors of urokinase and blood vessel formation |
| 02/03/2000 | WO2000005244A1 HUMAN BOMBESIN RECEPTOR SUBTYPE-3sb |
| 02/03/2000 | WO2000005239A1 Novel 6-deoxy erythromycin derivatives, method for preparing same and use as medicines |
| 02/03/2000 | WO2000005216A1 Il-8 receptor antagonists |
| 02/03/2000 | WO2000004939A1 Dental pin |
| 02/03/2000 | WO2000004937A1 Flat flexible materials |
| 02/03/2000 | WO2000004925A1 Slow release formulations comprising anionic polysaccharide |
| 02/03/2000 | WO2000004923A1 Scrp-5: secreted cysteine rich protein-5 |
| 02/03/2000 | WO2000004922A1 Vaccines against escherichia coli o157 infection |
| 02/03/2000 | WO2000004921A1 Avian leukosis virus subgroup j envelope gene product for diagnosis and vaccine |
| 02/03/2000 | WO2000004920A2 Method of vaccination of newly hatched poultry |
| 02/03/2000 | WO2000004919A2 Live attenuated salmonella vaccines to control avian pathogens |
| 02/03/2000 | WO2000004908A1 Composite biocidal particles |
| 02/03/2000 | WO2000004907A1 An antilipemic formulation |
| 02/03/2000 | WO2000004900A1 Substituted benzimidazole antiviral agents |
| 02/03/2000 | WO2000004891A2 Anti-ulcer composition |
| 02/03/2000 | WO2000004882A1 Formulations of anionic polysaccharides |
| 02/03/2000 | WO2000004881A1 Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method |
| 02/03/2000 | WO2000004877A1 Suppository formulations comprising anionic polysaccharide |
| 02/03/2000 | WO2000004863A2 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 02/03/2000 | WO1999064464A3 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means |
| 02/03/2000 | WO1999064417A3 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them |
| 02/03/2000 | WO1999064001A3 Methods and compositions for increasing penetration of hiv protease inhibitors |
| 02/03/2000 | WO1999063929A3 Multibinding inhibitors of microsomal triglyceride transferase protein |
| 02/03/2000 | WO1999061097A3 Alpha emitting constructs and uses thereof |
| 02/03/2000 | WO1999061052A3 Oral immunization with papillomavirus virus-like particles |
| 02/03/2000 | WO1999061049A3 Model for infection by a pathogen using administration of nucleic acids |
| 02/03/2000 | WO1999058145A3 Immunomodulators for vaccines |
| 02/03/2000 | WO1999057142A3 Vaccine for $i(pseudomonas aeruginosa) |
| 02/03/2000 | WO1999056772A3 Hepatitis vaccine |
| 02/03/2000 | WO1999051748A3 Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| 02/03/2000 | WO1999024589B1 Lysozym-analogous proteins and peptide having an anti-microbial activity, production of the same and use thereof |
| 02/03/2000 | CA2714833A1 Vaccines against escherichia coli o157 infection |
| 02/03/2000 | CA2339045A1 Anti hepatitis c virus antibody and uses thereof |
| 02/03/2000 | CA2338741A1 Il-8 receptor antagonists |
| 02/03/2000 | CA2338555A1 Live attenuated salmonella vaccines to control avian pathogens |
| 02/03/2000 | CA2338524A1 Inhibitors of urokinase and blood vessel formation |
| 02/03/2000 | CA2338299A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 02/03/2000 | CA2338147A1 Substituted benzimidazole antiviral agents |
| 02/03/2000 | CA2336250A1 Anti-ccr2 antibodies and methods of use therefor |
| 02/03/2000 | CA2335655A1 Keratinocyte derived interferon |
| 02/03/2000 | CA2335646A1 Genes of the dead box protein family, their expression products and use |
| 02/02/2000 | EP0976752A1 C-2 S/O- and S/N-Formaldehyde acetal derivatives of carbapenem antibiotics |
| 02/02/2000 | EP0976734A2 Selective inhibitors of viral or bacterial neuraminidase |
| 02/02/2000 | EP0976402A2 Vaccines for prevention of gram-negative bacterial infections and endotoxin-related diseases |
| 02/02/2000 | EP0975809A1 Novel screening methods to identify agents that selectively inhibit hepatitis c virus replication |
| 02/02/2000 | EP0975774A2 Bacterial plasmids |
| 02/02/2000 | EP0975773A1 Dna sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same |
| 02/02/2000 | EP0975761A1 Recombinant human beta interferon with enhanced solubility |
| 02/02/2000 | EP0975680A1 Interactive system for substance presentation and elimination |
| 02/02/2000 | EP0975663A1 Helicobacter pylori antigens |
| 02/02/2000 | EP0975662A1 Hepatitis c ns3 protease inhibitors |
| 02/02/2000 | EP0975654A1 Composition and method for treatment of cmv infections |
| 02/02/2000 | EP0975636A1 Novel compounds |
| 02/02/2000 | EP0975633A1 5,6,7-trisubstituted-4-aminopyridol 2,3-d]pyrimidine compounds |
| 02/02/2000 | EP0975632A1 Alkaloid halide salts of swainsonine and methods of use |
| 02/02/2000 | EP0975597A1 Quinoline derivatives, having in particular antiviral properties, preparation and biological applications thereof |
| 02/02/2000 | EP0975573A1 Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity |
| 02/02/2000 | EP0975369A1 Polyethylene glycol-interferon alpha conjugates for therapy of infection |
| 02/02/2000 | EP0975361A1 Methods of modulating immune coagulation |
| 02/02/2000 | EP0975359A1 Potentiation of the immune response through delivery of compounds binding a cytoplasmic dipeptidase |
| 02/02/2000 | EP0975354A1 Ligand/lytic peptide compositions and methods of use |
| 02/02/2000 | EP0975342A1 Pharmaceutical formulations comprising amoxocyllin and clavulanate |